Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science



Rating:

Share or cite this content

Citations should be made in the following way:
O. J. McElvaney, D. A. Bergin, T. Adage, J. H. Slingsby, A. J. Kungl, M. R. Bartley, E. P. Reeves, N. G. McElvaney (Dublin, Ireland; Reininghausstrasse, Austria). The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples. Eur Respir J 2013; 42: Suppl. 57, 2108

Member's Comments

No comment yet.

Related content which might interest you: α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Regulation of interleukin-8 by miR-17 during chronic inflammation in cystic fibrosis Source: International Congress 2015 – The multiple faces of host defense Year: 2015 Anti-inflammatory cytokines in cystic fibrosis lung disease Source: Eur Respir J 2006; 28: 581-587 Year: 2006 Characterization of cystic fibrosis airway epithelium in vitro Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis Source: Eur Respir J 2009; 34: 655 Year: 2009 Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 CFTR-dependent deficiency in alternatively-activated macrophages in cystic fibrosis Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Pro-inflammatory cytokines in cystic fibrosis lungs Source: Eur Respir J 2005; 26: Suppl. 49, 403s Year: 2005 Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease Source: Eur Respir J 2011; 37: 1378-1385 Year: 2011 Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction Source: Eur Respir J 2004; 23: 846-850 Year: 2004 Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-β kinase pathway Source: Eur Respir J 2003; 21: 574-581 Year: 2003 The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008 PBI-compound, a novel first-in-class anti-inflammatory/fibrotic compound, reduces bleomycin-induced pulmonary fibrosis by regulating inflammatory cytokines in bronchoalveolar fluid Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 The cytokine interleukin-17 is raised in the airway of people with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease Source: Eur Respir J 2006 Oct 01;28(4):824-831 Year: 2006 Role of TGF-beta and IFN-gamma in interstitial pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 719s Year: 2004 Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients Source: Eur Respir J 2014; 44: 802-805 Year: 2014 Expression of macrophage migration inhibitory factor in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Circulating inflammatory cytokines in adult cystic fibrosis patients Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009